BAY2701250
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY2701250, covering 2025-05-28 to 2025-05-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection) [Phase 1]